4,4,6-Trimethyl-2-(3,3,3-trifluoroprop-1-en-2-yl)-1,3,2-dioxaborinane, 98.0%, 250mg

6-(4-Bromo-phenyl)-imidazo[2,1-b]thiazole-5-carboxaldehyde, 1g

2-Chloro-5-methylpyridine 1-oxide, 95.0%, 5g

6-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carboxylic acid, 95.0%, 5g

N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-1-ethanamine, 95.0%, 10g

2-azaspiro[3.3]heptan-6-one; 2,2,2-trifluoroacetic acid, 95.0%, 25g

(3E)-3-[(dimethylamino)methylene]tetrahydro-4H-pyran-4-one, 95%, 250mg

1-(4-Chloro-3-(trifluoromethyl)phenyl)-1H-pyrrole, 97%, 10g

Fmoc-His(Trt)-OH, 98%, 5g

Aleación según Devarda, pa, 500 g, envase de vidrio

1-(4-Methyl-piperazin-1-yl)-propan-2-ol, 1g

6-METHOXY-1,2,3,4-TETRAHYDROCARBAZOLE, 97.0%, 1g

3-(9H-carbazol-9-yl)propan-1-ol, 98%, 5g